When does ABVC BIOPHARMA INC (ABVC) report earnings?
ABVC BIOPHARMA INC (ABVC) will report earnings on 2026-04-13, after the market close.
ABVC BIOPHARMA INC (ABVC) Forecast, Price Target & Analyst Ratings
NASDAQ:ABVC • US00091F3047
Current stock price
1.22 USD
-0.11 (-8.27%)
At close:
1.22 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABVC BIOPHARMA INC (ABVC).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $1.22 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
ABVC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ABVC.
In the previous month the buy percentage consensus was at a similar level.
ABVC was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-16 | Maxim Group | Downgrade | Buy -> Hold |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 13, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 970K 169.44% | 152.4K -84.29% | 509.6K 234.38% | 4.256M 735.16% | |
| EBITDA YoY % growth | -15.09M -28.97% | -6.738M 55.35% | -4.673M 30.65% | N/A | |
| EBIT YoY % growth | -15.11M -29.04% | -6.767M 55.22% | -4.705M 30.47% | -19.358M -311.41% | |
| Operating Margin | -1,557.73% | -4,440.09% | -923.31% | -454.83% | |
| EPS YoY % growth | N/A -126.09% | N/A 94.62% | N/A -57.14% | -0.47 -4.55% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ABVC BIOPHARMA INC / ABVC Forecast FAQ
What is the consensus rating for ABVC BIOPHARMA INC (ABVC) stock?
The consensus rating for ABVC BIOPHARMA INC (ABVC) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.